These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37395989)

  • 1. Bone metastatic cancer of unknown primary at initial presentation.
    Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
    Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
    Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
    BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
    Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
    Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancers of unknown primary: Survival by histologic type, demographic features, and treatment in the U.S. Military Health System.
    Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
    Cancer Epidemiol; 2023 Feb; 82():102316. PubMed ID: 36571909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
    Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia.
    Boys EL; Gao B; Grimison P; Sutherland S; MacKenzie KL; Reddel RR; Liu J
    Cancer Med; 2024 Mar; 13(6):e7052. PubMed ID: 38523552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
    Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
    Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
    Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
    PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
    Shafqat H; Ali S; Salhab M; Olszewski AJ
    Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
    Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
    Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?
    Song K; Song J; Chen F; Lin K; Ma X; Jiang J
    Clin Orthop Relat Res; 2019 Mar; 477(3):573-583. PubMed ID: 30762691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
    Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
    Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018).
    Wang S; Yin M; Wang P; Folefac E; Monk JP; Tabung FK; Clinton SK
    Front Oncol; 2023; 13():1165188. PubMed ID: 37361592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
    Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
    BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study.
    Natale C; Leinwand GZ; Chiang J; Silberstein JL; Krane LS
    Clin Genitourin Cancer; 2019 Oct; 17(5):380-388. PubMed ID: 31395362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.